The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 18, 2024

Filed:

Dec. 21, 2020
Applicant:

University of Virginia Patent Foundation, Charlottesville, VA (US);

Inventors:

Karen D. Fairchild, Charlottesville, VA (US);

Douglas E. Lake, Charlottesville, VA (US);

Brynne Sullivan, Charlottesville, VA (US);

Assignee:

University of Virginia Patent Foundation, Charlottesville, VA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 5/1455 (2006.01); G16H 15/00 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
A61B 5/7275 (2013.01); A61B 5/1455 (2013.01); A61B 5/14551 (2013.01); A61B 5/48 (2013.01); G16H 50/30 (2018.01); A61B 2503/045 (2013.01); A61M 2230/205 (2013.01); G16H 15/00 (2018.01);
Abstract

A method and system for generating pulse oximetry predictive scores (POPS) for predicting adverse outcomes in preterm infants. The method comprising generating a POPS via a predictive algorithm which incorporates cross-correlation of heart rate and SpO2 calculated on archived pulse oximetry data of multiple preterm infants, and predicting a pathology of a preterm infant based on the generated POPS, wherein the pathology is intraventricular hemorrhage, late-onset sepsis, necrotizing enterocolitis, bronchopulmonary dysplasia, or retinopathy of prematurity, and informing a user of an opportunity to: identify the preterm infant as a highest risk infant and perform additional surveillance of or therapeutic intervention on the preterm infant, identify the preterm infant for participation in a clinical trial based on a risk profile associated with the POPS, and treat said preterm infant for the pathology.


Find Patent Forward Citations

Loading…